Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Croft

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Journal of Clinical Investigation|April 3, 2008
Kinetoplastids: related protozoan pathogens, different diseasesKen Stuart, Reto Brun, Simon Croft, et al.
Microbes and Infection|March 14, 2007
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?Suman Rijal, Vanessa Yardley, François Chappuis, et al.
Journal of Proteome Research|November 5, 2014
Metabolic, immune, and gut microbial signals mount a systems response to Leishmania major infectionSabrina D Lamour, Kirill A Veselkov, Joram M Posma, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 3, 2006
Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from NepalThierry Laurent, Suman Rijal, Vanessa Yardley, et al.
The Journal of Infectious Diseases|September 23, 2006
American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?Vanessa Yardley, Nimer Ortuno, Alejandro Llanos-Cuentas, et al.
Journal of Medicinal Chemistry|February 19, 2008
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agentsCaterina Fattorusso, Giuseppe Campiani, Gagan Kukreja, et al.
Journal of Medicinal Chemistry|February 19, 2008
Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studiesSandra Gemma, Giuseppe Campiani, Stefania Butini, et al.
Journal of Medicinal Chemistry|December 31, 2008
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarialsSandra Gemma, Giuseppe Campiani, Stefania Butini, et al.
Science (New York, N.Y.)|June 8, 2019
Science-based wildlife disease responseJoaquín Vicente, Marco Apollonio, Jose A Blanco-Aguiar, et al.
Parasites & Vectors|January 28, 2016
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, IndiaMary M Cameron, Alvaro Acosta-Serrano, Caryn Bern, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Clinical Investigation|April 3, 2008
Kinetoplastids: related protozoan pathogens, different diseasesKen Stuart, Reto Brun, Simon Croft, et al.
Microbes and Infection|March 14, 2007
Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?Suman Rijal, Vanessa Yardley, François Chappuis, et al.
Journal of Proteome Research|November 5, 2014
Metabolic, immune, and gut microbial signals mount a systems response to Leishmania major infectionSabrina D Lamour, Kirill A Veselkov, Joram M Posma, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 3, 2006
Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from NepalThierry Laurent, Suman Rijal, Vanessa Yardley, et al.
The Journal of Infectious Diseases|September 23, 2006
American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?Vanessa Yardley, Nimer Ortuno, Alejandro Llanos-Cuentas, et al.
Journal of Medicinal Chemistry|February 19, 2008
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agentsCaterina Fattorusso, Giuseppe Campiani, Gagan Kukreja, et al.
Journal of Medicinal Chemistry|February 19, 2008
Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studiesSandra Gemma, Giuseppe Campiani, Stefania Butini, et al.
Journal of Medicinal Chemistry|December 31, 2008
Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarialsSandra Gemma, Giuseppe Campiani, Stefania Butini, et al.
Science (New York, N.Y.)|June 8, 2019
Science-based wildlife disease responseJoaquín Vicente, Marco Apollonio, Jose A Blanco-Aguiar, et al.
Parasites & Vectors|January 28, 2016
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, IndiaMary M Cameron, Alvaro Acosta-Serrano, Caryn Bern, et al.
Pageof 3